ALS traded at 24.57 this Wednesday March 4th, decreasing 1.02 or 3.99 percent since the previous trading session. Looking back, over the last four weeks, ALS lost 2.89 percent. Over the last 12 months, its price rose by 52.89 percent. Looking ahead, we forecast ALS to be priced at 25.50 by the end of this quarter and at 23.94 in one year, according to Trading Economics global macro models projections and analysts expectations.
ALS Limited is an Australian-based company, which is engaged in providing laboratory testing, inspection, certification and verification solutions. The Company operates through three segments: Life Sciences, Commodities, and Industrial. Its Life Sciences segment provides analytical testing, sampling services and remote monitoring for the environmental, food, pharmaceutical, and consumer product markets. Its Commodities segment provides testing services for the global mining industry in four business streams, which includes geochemistry, metallurgy, inspection, and coal quality. Its Industrial segment is a provider of diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. The Company operates from approximately 350 sites in over 65 countries across Africa, Asia, Australia, Europe and the Americas.